InProteins

inproteins.com ↗ ·A Coruña ·Other

InProteins (legal name In Proteins For All, S.L.) is a Spanish foodtech company developing plant-based protein ingredients — concentrates, isolates, hydrolysates and custom powders — using a proprietary hybrid green-chemistry/biotech extraction process. It is building Spain's first integrated plant-based protein production plant in Curtis, A Coruña (Galicia), backed by a joint investment from beer group Hijos de Rivera and the Xunta de Galicia's public venture arm Xesgalicia (total project cost reported near €18M), with the plant expected to start operations in late 2026; it also runs an R&D facility (Imagine Labs) in Camas, Seville.

Founded

2022

Founders

Total funds raised

€7.5M

SectorsFoodTech, Alternative Proteins, Biotechnology, Sustainable Food Production Start-up MapFoodtech & Agtech › Alternative protein & novel ingredients

Suggest a correction

Founders

Ana Rosa Caamaño Vara

CEO & Co-founder

Héctor Ara Sanz

Co-founder

Global models 5

Perfect Day

United States · perfectday.com ↗

Uses biotech fermentation to produce animal-free protein ingredients sold B2B to food manufacturers, the same ingredient-supplier model as InProteins.

$750MComparable

Ÿnsect

France · ynsect.com ↗

Built large-scale industrial facilities to manufacture alternative protein ingredients from insects for food/feed customers, mirroring InProteins' industrial ingredient-plant approach.

$600MComparable

Nature's Fynd

United States · naturesfynd.com ↗

Fermentation-based protein ingredient producer supplying food manufacturers, comparable biotech-to-ingredient production model.

$500MComparable

Motif FoodWorks

United States · motif.inc ↗

Develops and manufactures functional plant-based protein ingredients for food companies, closely matching InProteins' B2B ingredient focus.

$345MComparable

ENOUGH

United Kingdom · www.enough-food.com ↗

Operates industrial-scale mycoprotein production plants supplying alternative-protein ingredients, the closest match to InProteins' plant-manufacturing model.

$111MComparable